Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study

BACKGROUND: For the two-thirds of patients with epilepsy who achieve seizure remission on antiseizure medications (ASMs), patients and clinicians must weigh the pros and cons of long-term ASM treatment. However, little work has evaluated how often ASM discontinuation occurs in practice. We describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Terman, Samuel W., Niznik, Joshua D., Slinger, Geertruida, Otte, Willem M., Braun, Kees P. J., Aubert, Carole E., Kerr, Wesley T., Boyd, Cynthia M., Burke, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434838/
https://www.ncbi.nlm.nih.gov/pubmed/36050646
http://dx.doi.org/10.1186/s12883-022-02852-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434838/
https://www.ncbi.nlm.nih.gov/pubmed/36050646
http://dx.doi.org/10.1186/s12883-022-02852-6

Ejemplares similares